Skip to content

Price / sales at other companies

Pfizer logo
PfizerPFE
2.5×+0.2×
Rogers Corporation logo
Rogers CorporationROG
2.3×+0.8×
Merck & Co. logo
Merck & Co.MRK
4.5×+1.0×
Gilead Sciences logo
Gilead SciencesGILD
5.8×+1.0×
Nuvation Bio logo
Nuvation BioNUVB
10.4×-44.0×
Immunome logo
ImmunomeIMNM
616.2×+563×

Other financials

Income statement

See full
Revenue--100%
Operating income-$30.9M+27.9%
Net income-$33.4M+22.8%
EPS (diluted)-$2.15+23.2%

Balance sheet

See full
Cash & equivalents$161.7M-25.3%
Total debt$180.9M+69.8%
Total equity-$21.0M-122%
Total assets$184.0M-24.2%

Cash flow

See full
Operating cash flow-$38.0M-5.9%
CapEx--100%
Free cash flow-$38.0M-5.9%

Valuation

See full
Market cap$1.4B+385%
Enterprise value$1.42B+982%

Profitability

See full
Operating margin-10,386.5%-5,025pp
Net margin-10,773.5%-878,492pp
FCF margin-9,986.5%-4,727pp

Returns & leverage

See full
Return on equity-197.8%-2,158pp
Debt / equity13.4×+13.3×
Current ratio6.5×+1.3×

Where this comes from

Calculated from Inhibrx Biosciences, Inc.’s reported figures.

Based on the most recent quarter.

The official record: Inhibrx Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Inhibrx Biosciences, Inc.'s price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Inhibrx Biosciences, Inc.'s price / sales?
Inhibrx Biosciences, Inc. (INBX) reported price / sales of 883.8× in Q4 2025.
How has Inhibrx Biosciences, Inc.'s price / sales changed year-over-year?
Inhibrx Biosciences, Inc.'s price / sales decreased by 20.7% year-over-year, from 1,114.6× to 883.8×.
What is the long-term trend for Inhibrx Biosciences, Inc.'s price / sales?
Over 2 years (2023 to 2025), Inhibrx Biosciences, Inc.'s price / sales has grown at a 70.1% compound annual growth rate (CAGR), from 305.6× to 883.8×.
What does price / sales mean?
Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.